These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 279399)

  • 1. Selective destruction of human leukemic cells by alkyl-lysophospholipids.
    Andreesen R; Modolell M; Weltzien HU; Eibl H; Common HH; Löhr GW; Munder PG
    Cancer Res; 1978 Nov; 38(11 Pt 1):3894-9. PubMed ID: 279399
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.
    Andreesen R; Modolell M; Oepke GH; Common H; Löhr GW; Munder PG
    Anticancer Res; 1982; 2(1-2):95-100. PubMed ID: 7114806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.
    Vogler WR; Whigham E; Bennett WD; Olson AC
    Exp Hematol; 1985 Aug; 13(7):629-33. PubMed ID: 3861326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.
    Modolell M; Andreesen R; Pahlke W; Brugger U; Munder PG
    Cancer Res; 1979 Nov; 39(11):4681-6. PubMed ID: 498095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow.
    Koeffler HP; Lowe L; Golde DW
    Cancer Treat Rep; 1980 Jan; 64(1):105-9. PubMed ID: 6929726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
    Chou TC; Arlin Z; Clarkson BD; Phillips FS
    Cancer Res; 1977 Oct; 37(10):3561-70. PubMed ID: 332337
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.
    Berdel WE; Fromm M; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
    Cancer Res; 1983 Nov; 43(11):5538-43. PubMed ID: 6577950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
    Honma Y; Kasukabe T; Hozumi M; Tsushima S; Nomura H
    Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
    Long RC; Small WC; Brynes RK; Tidwell T; Goldstein JH; Vogler WR
    Cancer Res; 1983 Feb; 43(2):770-5. PubMed ID: 6571718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature dependence of leukemic cell destruction by alkyl-lysophospholipids (NSC 324368).
    Andreesen R; Modolell M; Oepke GH; Munder PG
    Exp Hematol; 1983 Jul; 11(6):564-70. PubMed ID: 6617791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in effects of alkyl-lysophospholipids and verapamil on vincristine transport in vincristine-sensitive and -resistant human myelogenous leukemia K562.
    Tsuruo T; Saito H
    Anticancer Res; 1987; 7(1):39-43. PubMed ID: 3471174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
    Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP
    Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205
    [No Abstract]   [Full Text] [Related]  

  • 13. Perturbation of the generation cycle of human leukemic blast cells in vivo by vincristine.
    Ernst P
    Biomedicine; 1973 Nov; 18(6):484-90. PubMed ID: 4522355
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic effects of alkyl-lysophospholipids on human bone marrow and de novo leukaemias. A short overview.
    Wötzel M; Brachwitz H; Langen P; Thierbach V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):771-6. PubMed ID: 1713880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
    Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F
    Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response.
    Kessel D; Hall TC; Roberts D
    Cancer Res; 1968 Mar; 28(3):564-70. PubMed ID: 5238559
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.
    Vogler WR; Whigham EA; Somberg LB; Long RC; Winton EF
    Exp Hematol; 1984 Aug; 12(7):569-74. PubMed ID: 6540197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
    Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.
    Atzpodien J; Gulati SC; Clarkson BD
    Cancer Res; 1986 Oct; 46(10):4892-5. PubMed ID: 3756850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.